Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 12 results when searching "Tofacitinib"

DOCUMENT

Jul 2020 - LJF Summary of Amendments

Prepared July 2020 AG Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reasons fo...

DOCUMENT

04/12/2024 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 04 December 2024 Page 1 of 15 East Region Formulary Committee Minutes Date: 04 December 2024 Time: 2.00pm – 4:30pm Location: MS Teams Present: Carla Capaldi ...

DOCUMENT

28/09/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 28 September 2022 Page 1 of 17 East Region Formulary Committee Minutes Date: 28 September 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Sen...

DOCUMENT

09/08/2023 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 9 August 2023 Page 1 of 16 East Region Formulary Committee Minutes Date: 9 August 2023 Time: 2.00pm – 4.30pm Location: MS Teams Present: Ruth Cameron Advan...

DOCUMENT

07/06/2023 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 7 June 2023 Page 1 of 17 East Region Formulary Committee Minutes Date: 7 June 2023 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning (Acting) Assoc...

DOCUMENT

30/11/2022 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 30 November 2022 Page 1 of 21 East Region Formulary Committee Minutes Date: 30 November 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Senio...

DOCUMENT

07/08/2024 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 07 August 2024 Page 1 of 19 East Region Formulary Committee Minutes Date: 07 August 2024 Time: 2.00pm – 4.45pm Location: MS Teams Present: Carla Capaldi ...

FORMULARY DECISION

Tofacitinib : Xeljanz

SMC2463 : For the treatment of adult patients with active ankylosing spondylitis (AS) who have responded inadequately to conventional therapy.

FORMULARY DECISION

Tofacitinib : Xeljanz

1298/18 : In combination with methotrexate for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or mor...